Lower respiratory tract infections can be difficult to diagnose because bacterial and viral infections often cause similar symptoms. The FebriDx point-of-care test helps healthcare professionals make faster and more informed treatment decisions by providing results in about 10 minutes from a simple finger-prick blood sample. It measures biomarkers that help indicate whether an infection is likely viral or bacterial, supporting better clinical decisions and reducing unnecessary antibiotic use.
A recent study found that healthcare providers valued the test because it increased confidence during patient consultations and improved communication about treatment choices. While no test replaces clinical judgment, FebriDx is a useful tool that supports accurate diagnosis and encourages responsible antibiotic prescribing in primary care settings.
